Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MA vs MRNA✓SelectedUSD · MRNAMA vs MRNA performance historyLatest closeAs of-0.15%11/20
Stock and ETF performance explorer

MA vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+233.2%
MRNA return
+786.4%
Excess return
-553.1%
Maximum drawdown
-41.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-0.1%-2.2%+2.0%-0.1%
7D-5.4%-12.7%+7.3%-5.1%
30D+0.5%-20.7%+21.1%+0.9%
3M+9.2%+46.3%-37.1%+8.2%
6M+26.0%+305.2%-279.2%+19.8%
YTD+10.3%+561.2%-551.0%+2.6%
1Y+19.3%+772.1%-752.8%+9.8%
3Y+57.5%+147.0%-89.5%+48.9%
5Y+89.7%-26.1%+115.8%+80.6%
All+233.2%+786.4%-553.1%+200.7%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling